Key result
Statins in children with FH are linked to a ~36% LDL-C reduction without impairing physical development.
Why the study?
To evaluate outcomes and share 20 years of experience with comprehensive care and statin treatment in pediatric patients with familial hypercholesterolemia at a single academic center.
Does statin treatment reduce cholesterol levels and is it safe in children with familial hypercholesterolemia?
Population
84 children aged 1-18 years with familial hypercholesterolemia
Comparison
Statin treatment vs non-pharmacological care
Design
Single-center retrospective cohort study
Follow-up
Mean 33.6 months
Authors
Loading...
May support statin consideration in pediatric familial hypercholesterolemia; leaves open need for randomized trials before practice change.
Cohort (n=84)
No
Does statin treatment reduce cholesterol levels and is it safe in children with familial hypercholesterolemia?
Absolute Event Rate: 36% vs 13.7%
p-value: p=<0.001
Statin treatment in children with familial hypercholesterolemia is effective in reducing LDL-cholesterol by 33% and is generally safe without harming physical development.
Abramowicz et al. (2023) conducted a cohort in Familial hypercholesterolemia (n=84). Statin treatment vs. Diet alone was evaluated on Mean reduction in LDL-cholesterol during follow-up (p=<0.001). Statin treatment in children with familial hypercholesterolemia was associated with a 36% reduction in LDL-cholesterol from baseline, demonstrating high efficacy and a good safety profile without harming physical development.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: